Muscle MRI in patients with dysferlinopathy: pattern recognition and implications for clinical trials
Jordi Diaz-Manera, Roberto Fernandez-Torron, Jaume LLauger, Meredith K James, Anna Mayhew, Fiona E Smith, Ursula R Moore, Andrew M Blamire, Pierre G Carlier, Laura Rufibach, Plavi Mittal, Michelle Eagle, Marni Jacobs, Tim Hodgson, Dorothy Wallace, Louise Ward, Mark Smith, Roberto Stramare, Alessandro Rampado, Noriko Sato, Takeshi Tamaru, Bruce Harwick, Susana Rico Gala, Suna Turk, Eva M Coppenrath, Glenn Foster, David Bendahan, Yann Le Fur, Stanley T Fricke, Hansel Otero, Sheryl L Foster, Anthony Peduto, Anne Marie Sawyer, Heather Hilsden, Hanns Lochmuller, Ulrike Grieben, Simone Spuler, Carolina Tesi Rocha, John W Day, Kristi J Jones, Diana X Bharucha-Goebel, Emmanuelle Salort-Campana, Matthew Harms, Alan Pestronk, Sabine Krause, Olivia Schreiber-Katz, Maggie C Walter, Carmen Paradas, Jean-Yves Hogrel, Tanya Stojkovic, Shin'ichi Takeda, Madoka Mori-Yoshimura, Elena Bravver, Susan Sparks, Luca Bello, Claudio Semplicini, Elena Pegoraro, Jerry R Mendell, Kate Bushby, Volker Straub, Jain COS Consortium, Adrienne Arrieta, Jia Feng, Esther Hwang, Elaine Lee, Isabel Illa, Eduard Gallardo, Irene Pedrosa Hernández, Izaskun Belmonte Jimeno, Elke Maron, Juliana Prügel, Mohammed Sanjak, Jackie Sykes, Linda P Lowes, Lindsay Alfano, Katherine Berry, Brent Yetter, Bernard Lapeyssonie, Attarian Shahram, Testot-Ferry Albane, Simone Thiele, Karen Bettinson, Robert Muni Lofra, Elizabeth Harris, Dionne Moat, Debra Galley, Chiara Calore, Teresa Gidaro, Laurent Servais, Aurélie Canal, Gwenn Ollivier, Valérie Decostre, Cyrille Theis, Oumar Diabaté, Julaine Florence, Linda Schimmoeller, Catherine Siener, Jeanine Schierbecker, Bosco Méndez, Pilar Carbonell, Nieves Sanchez-Aguilar, Macarena Cabrera, Yolanda Morgado, Richard Gee, Tina Duong, Jennifer Perez, Nigel F Clarke, Sarah Sandaradura, Roula Ghaoui, Kayla Cornett, Clare Miller, Meghan Harman, Kristy Rose, Yoko Kobayashi, Hiroyuki Yajima, Chikako Sakamoto, Takayuki Tateishi, Ai Ashida, Takahiro Nakayama, Kazuhiko Segawa, Sachiko Ohtaguro, Harumasa Nakamura, Maki Ohhata, En Kimura, Makiko Endo, Brittney Drogo, Nora Brody, Meganne E Leach, Allyn Toles, Jordi Diaz-Manera, Roberto Fernandez-Torron, Jaume LLauger, Meredith K James, Anna Mayhew, Fiona E Smith, Ursula R Moore, Andrew M Blamire, Pierre G Carlier, Laura Rufibach, Plavi Mittal, Michelle Eagle, Marni Jacobs, Tim Hodgson, Dorothy Wallace, Louise Ward, Mark Smith, Roberto Stramare, Alessandro Rampado, Noriko Sato, Takeshi Tamaru, Bruce Harwick, Susana Rico Gala, Suna Turk, Eva M Coppenrath, Glenn Foster, David Bendahan, Yann Le Fur, Stanley T Fricke, Hansel Otero, Sheryl L Foster, Anthony Peduto, Anne Marie Sawyer, Heather Hilsden, Hanns Lochmuller, Ulrike Grieben, Simone Spuler, Carolina Tesi Rocha, John W Day, Kristi J Jones, Diana X Bharucha-Goebel, Emmanuelle Salort-Campana, Matthew Harms, Alan Pestronk, Sabine Krause, Olivia Schreiber-Katz, Maggie C Walter, Carmen Paradas, Jean-Yves Hogrel, Tanya Stojkovic, Shin'ichi Takeda, Madoka Mori-Yoshimura, Elena Bravver, Susan Sparks, Luca Bello, Claudio Semplicini, Elena Pegoraro, Jerry R Mendell, Kate Bushby, Volker Straub, Jain COS Consortium, Adrienne Arrieta, Jia Feng, Esther Hwang, Elaine Lee, Isabel Illa, Eduard Gallardo, Irene Pedrosa Hernández, Izaskun Belmonte Jimeno, Elke Maron, Juliana Prügel, Mohammed Sanjak, Jackie Sykes, Linda P Lowes, Lindsay Alfano, Katherine Berry, Brent Yetter, Bernard Lapeyssonie, Attarian Shahram, Testot-Ferry Albane, Simone Thiele, Karen Bettinson, Robert Muni Lofra, Elizabeth Harris, Dionne Moat, Debra Galley, Chiara Calore, Teresa Gidaro, Laurent Servais, Aurélie Canal, Gwenn Ollivier, Valérie Decostre, Cyrille Theis, Oumar Diabaté, Julaine Florence, Linda Schimmoeller, Catherine Siener, Jeanine Schierbecker, Bosco Méndez, Pilar Carbonell, Nieves Sanchez-Aguilar, Macarena Cabrera, Yolanda Morgado, Richard Gee, Tina Duong, Jennifer Perez, Nigel F Clarke, Sarah Sandaradura, Roula Ghaoui, Kayla Cornett, Clare Miller, Meghan Harman, Kristy Rose, Yoko Kobayashi, Hiroyuki Yajima, Chikako Sakamoto, Takayuki Tateishi, Ai Ashida, Takahiro Nakayama, Kazuhiko Segawa, Sachiko Ohtaguro, Harumasa Nakamura, Maki Ohhata, En Kimura, Makiko Endo, Brittney Drogo, Nora Brody, Meganne E Leach, Allyn Toles
Abstract
Background and objective: Dysferlinopathies are a group of muscle disorders caused by mutations in the DYSF gene. Previous muscle imaging studies describe a selective pattern of muscle involvement in smaller patient cohorts, but a large imaging study across the entire spectrum of the dysferlinopathies had not been performed and previous imaging findings were not correlated with functional tests.
Methods: We present cross-sectional T1-weighted muscle MRI data from 182 patients with genetically confirmed dysferlinopathies. We have analysed the pattern of muscles involved in the disease using hierarchical analysis and presented it as heatmaps. Results of the MRI scans have been correlated with relevant functional tests for each region of the body analysed.
Results: In 181 of the 182 patients scanned, we observed muscle pathology on T1-weighted images, with the gastrocnemius medialis and the soleus being the most commonly affected muscles. A similar pattern of involvement was identified in most patients regardless of their clinical presentation. Increased muscle pathology on MRI correlated positively with disease duration and functional impairment.
Conclusions: The information generated by this study is of high diagnostic value and important for clinical trial development. We have been able to describe a pattern that can be considered as characteristic of dysferlinopathy. We have defined the natural history of the disease from a radiological point of view. These results enabled the identification of the most relevant regions of interest for quantitative MRI in longitudinal studies, such as clinical trials.
Clinical trial registration: NCT01676077.
Keywords: dysferlinopathy; muscle MRI; muscular dystrophy; outcome measures.
Conflict of interest statement
Competing interests: None declared.
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.
Figures
References
- Liu J, Aoki M, Illa I, et al. . Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy. Nat Genet 1998;20:31–6. 10.1038/1682
- Bashir R, Britton S, Strachan T, et al. . A gene related to Caenorhabditis elegans spermatogenesis factor fer-1 is mutated in limb-girdle muscular dystrophy type 2B. Nat Genet 1998;20:37–42. 10.1038/1689
- Nguyen K, Bassez G, Krahn M, et al. . Phenotypic study in 40 patients with dysferlin gene mutations: high frequency of atypical phenotypes. Arch Neurol 2007;64:1176–82. 10.1001/archneur.64.8.1176
- Illa I, Serrano-Munuera C, Gallardo E, et al. . Distal anterior compartment myopathy: a dysferlin mutation causing a new muscular dystrophy phenotype. Ann Neurol 2001;49:130–4. 10.1002/1531-8249(200101)49:1<130::AID-ANA22>;2-0
- Amato AA, Brown RH. Dysferlinopathies. Handb Clin Neurol 2011;101:111–8. 10.1016/B978-0-08-045031-5.00007-4
- Willis TA, Hollingsworth KG, Coombs A, et al. . Quantitative magnetic resonance imaging in limb-girdle muscular dystrophy 2I: a multinational cross-sectional study. PLoS One 2014;9:e90377 10.1371/journal.pone.0090377
- Bonati U, Hafner P, Schädelin S, et al. . Quantitative muscle MRI: A powerful surrogate outcome measure in Duchenne muscular dystrophy. Neuromuscul Disord 2015;25:679–85. 10.1016/j.nmd.2015.05.006
- Kesper K, Kornblum C, Reimann J, et al. . Pattern of skeletal muscle involvement in primary dysferlinopathies: a whole-body 3.0-T magnetic resonance imaging study. Acta Neurol Scand 2009;120:111–8. 10.1111/j.1600-0404.2008.01129.x
- Paradas C, Llauger J, Diaz-Manera J, et al. . Redefining dysferlinopathy phenotypes based on clinical findings and muscle imaging studies. Neurology 2010;75:316–23. 10.1212/WNL.0b013e3181ea1564
- Díaz J, Woudt L, Suazo L, et al. . Broadening the imaging phenotype of dysferlinopathy at different disease stages. Muscle Nerve 2016;54:203–10. 10.1002/mus.25045
- Jin S, Du J, Wang Z, et al. . Heterogeneous characteristics of MRI changes of thigh muscles in patients with dysferlinopathy. Muscle Nerve 2016;54:1072–9. 10.1002/mus.25207
- Harris E, Bladen CL, Mayhew A, et al. . The Clinical Outcome Study for dysferlinopathy. Neurol Genet 2016;2:e89 10.1212/NXG.0000000000000089
- Scott E, Eagle M, Mayhew A, et al. . Development of a functional assessment scale for ambulatory boys with Duchenne muscular dystrophy. Physiother Res Int 2012;17:101–9. 10.1002/pri.520
- Brooke MH, Griggs RC, Mendell JR, et al. . Clinical trial in Duchenne dystrophy. I. The design of the protocol. Muscle Nerve 1981;4:186–97. 10.1002/mus.880040304
- Vandervelde L, Van den Bergh PY, Goemans N, et al. . ACTIVLIM: a Rasch-built measure of activity limitations in children and adults with neuromuscular disorders. Neuromuscul Disord 2007;17:459–69. 10.1016/j.nmd.2007.02.013
- Fischer D, Kley RA, Strach K, et al. . Distinct muscle imaging patterns in myofibrillar myopathies. Neurology 2008;71:758–65. 10.1212/01.wnl.0000324927.28817.9b
- Díaz-Manera J, Alejaldre A, González L, et al. . Muscle imaging in muscle dystrophies produced by mutations in the EMD and LMNA genes. Neuromuscul Disord 2016;26:33–40. 10.1016/j.nmd.2015.10.001
- Tasca G, Iannaccone E, Monforte M, et al. . Muscle MRI in becker muscular dystrophy. Neuromuscul Disord 2012;22(Suppl 2):S100–6. 10.1016/j.nmd.2012.05.015
- Faridian-Aragh N, Wagner KR, Leung DG, et al. . Magnetic resonance imaging phenotyping of Becker muscular dystrophy. Muscle Nerve 2014;50:962–7. 10.1002/mus.24246
- Carboni N, Mura M, Marrosu G, et al. . Muscle imaging analogies in a cohort of patients with different clinical phenotypes caused by LMNA gene mutations. Muscle Nerve 2010;41:458–63. 10.1002/mus.21514
- Mercuri E, Bushby K, Ricci E, et al. . Muscle MRI findings in patients with limb girdle muscular dystrophy with calpain 3 deficiency (LGMD2A) and early contractures. Neuromuscul Disord 2005;15:164–71. 10.1016/j.nmd.2004.10.008
- Wattjes MP, Kley RA, Fischer D. Neuromuscular imaging in inherited muscle diseases. Eur Radiol 2010;20:2447–60. 10.1007/s00330-010-1799-2
- Fischer D, Walter MC, Kesper K, et al. . Diagnostic value of muscle MRI in differentiating LGMD2I from other LGMDs. J Neurol 2005;252:538–47. 10.1007/s00415-005-0684-4
- Díaz-Manera J, Llauger J, Gallardo E, et al. . Muscle MRI in muscular dystrophies. Acta Myol 2015;34:95–108.
- Carlier RY, Laforet P, Wary C, et al. . Whole-body muscle MRI in 20 patients suffering from late onset Pompe disease: Involvement patterns. Neuromuscul Disord 2011;21:791–9. 10.1016/j.nmd.2011.06.748
- Figueroa-Bonaparte S, Segovia S, Llauger J, et al. . Muscle MRI findings in childhood/adult onset pompe disease correlate with muscle function. PLoS One 2016;11:e0163493 10.1371/journal.pone.0163493
- Sarkozy A, Deschauer M, Carlier RY, et al. . Muscle MRI findings in limb girdle muscular dystrophy type 2L. Neuromuscul Disord 2012;22(Suppl 2):S122–9. 10.1016/j.nmd.2012.05.012
- Penttila S, Palmio J, Udd B. ANO5-related muscle diseases : Pagon RA, Adam MP, Ardinger HH, Seattle (WA): GeneReviews(R), 2012.
- Ten Dam L, van der Kooi AJ, Rövekamp F, et al. . Comparing clinical data and muscle imaging of DYSF and ANO5 related muscular dystrophies. Neuromuscul Disord 2014;24:1097–102. 10.1016/j.nmd.2014.07.004
- Okahashi S, Ogawa G, Suzuki M, et al. . Asymptomatic sporadic dysferlinopathy presenting with elevation of serum creatine kinase. Typical distribution of muscle involvement shown by MRI but not by CT. Intern Med 2008;47:305–7. 10.2169/internalmedicine.47.0519
- Hankiewicz K, Carlier RY, Lazaro L, et al. . Whole-body muscle magnetic resonance imaging in SEPN1-related myopathy shows a homogeneous and recognizable pattern. Muscle Nerve 2015;52:728–35. 10.1002/mus.24634
- Gómez-Andrés D, Dabaj I, Mompoint D, et al. . Pediatric laminopathies: whole-body magnetic resonance imaging fingerprint and comparison with sepn1 myopathy. Muscle Nerve 2016;54:192–202. 10.1002/mus.25018
- De la Torre C, Illa I, Faulkner G, et al. . Proteomics identification of differentially expressed proteins in the muscle of dysferlin myopathy patients. Proteomics Clin Appl 2009;3:486–97. 10.1002/prca.200800087
- Straub V, Carlier PG, Mercuri E. TREAT-NMD workshop: pattern recognition in genetic muscle diseases using muscle MRI: 25-26 February 2011, Rome, Italy. Neuromuscul Disord 2012;22(Suppl 2):S42–53. 10.1016/j.nmd.2012.08.002
- Damon BM, Li K, Bryant ND. Magnetic resonance imaging of skeletal muscle disease. Handb Clin Neurol 2016;136:827–42. 10.1016/B978-0-444-53486-6.00041-7
- Straub V, Balabanov P, Bushby K, et al. . Stakeholder cooperation to overcome challenges in orphan medicine development: the example of Duchenne muscular dystrophy. Lancet Neurol 2016;15:882–90. 10.1016/S1474-4422(16)30035-7
- Kim HK, Serai S, Lindquist D, et al. . Quantitative skeletal muscle MRI: Part 2, MR spectroscopy and T2 relaxation time mapping-comparison between boys with duchenne muscular dystrophy and healthy boys. AJR Am J Roentgenol 2015;205:W216–W223. 10.2214/AJR.14.13755
- Arpan I, Willcocks RJ, Forbes SC, et al. . Examination of effects of corticosteroids on skeletal muscles of boys with DMD using MRI and MRS. Neurology 2014;83:974–80. 10.1212/WNL.0000000000000775
- Morrow JM, Sinclair CD, Fischmann A, et al. . MRI biomarker assessment of neuromuscular disease progression: a prospective observational cohort study. Lancet Neurol 2016;15:65–77. 10.1016/S1474-4422(15)00242-2
Source: PubMed